- $208.21bn
- $231.69bn
- $64.17bn
- 94
- 68
- 50
- 82
Annual balance sheet for Merck & Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 8,062 | 8,096 | 13,192 | 7,093 | 13,689 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 7,851 | 9,230 | 10,110 | 11,072 | 11,119 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 27,764 | 30,266 | 35,722 | 32,168 | 38,782 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 17,986 | 19,279 | 22,768 | 24,488 | 25,149 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 91,588 | 105,694 | 109,160 | 106,675 | 117,106 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 27,327 | 23,872 | 24,239 | 25,694 | 28,420 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 66,271 | 67,510 | 63,169 | 69,094 | 70,793 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 25,317 | 38,184 | 45,991 | 37,581 | 46,313 |
Total Liabilities & Shareholders' Equity | 91,588 | 105,694 | 109,160 | 106,675 | 117,106 |
Total Common Shares Outstanding |